Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
- PMID: 31223257
- PMCID: PMC6559624
- DOI: 10.11613/BM.2019.020503
Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
Abstract
A modern diagnostic laboratory offers wide spectrum of coagulation assays utilized in the diagnosis and management of patients with haemostatic disorders, preoperative screening and anticoagulation therapy monitoring. The recent survey conducted among Croatian medical biochemistry and transfusion laboratories showed the existence of different practice policies in particular phases of laboratory process during coagulation testing and highlighted areas that need improvement. Lack of assay standardization together with non-harmonized test results between different measurement methods, can potentially lead to incorrect decisions in patient's treatment. Consequently, patient safety could be compromised. Therefore, recommended procedures related to preanalytical, analytical and postanalytical phases of prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer testing are provided in this review, aiming to help laboratories to generate accurate and reliable test results.
Keywords: blood coagulation tests; guidelines; haemostasis; harmonization; standardization.
Conflict of interest statement
Potential conflict of interest: None declared.
Similar articles
-
Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.Biochem Med (Zagreb). 2017 Feb 15;27(1):199-216. doi: 10.11613/BM.2017.022. Biochem Med (Zagreb). 2017. PMID: 28392741 Free PMC article.
-
Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.Pathology. 2021 Aug;53(5):623-627. doi: 10.1016/j.pathol.2020.10.017. Epub 2021 Jan 30. Pathology. 2021. PMID: 33526243
-
Effect of specimen collection on routine coagulation assays and D-dimer measurement.Clin Chem. 2004 Nov;50(11):2150-2. doi: 10.1373/clinchem.2004.036244. Clin Chem. 2004. PMID: 15502084 No abstract available.
-
Routine Coagulation.Clin Lab Med. 2024 Sep;44(3):527-539. doi: 10.1016/j.cll.2024.04.012. Epub 2024 Jun 4. Clin Lab Med. 2024. PMID: 39089756 Review.
-
[Diagnostic of blood coagulation].Hamostaseologie. 2008 Dec;28(5):320-34. Hamostaseologie. 2008. PMID: 19132163 Review. German.
Cited by
-
Saudi expert consensus on acquired hemophilia A diagnosis and management.J Taibah Univ Med Sci. 2024 Apr 27;19(3):566-574. doi: 10.1016/j.jtumed.2024.04.006. eCollection 2024 Jun. J Taibah Univ Med Sci. 2024. PMID: 38736896 Free PMC article.
-
Coagulation markers as independent predictors of prostate cancer aggressiveness: a retrospective cohort study.Sci Rep. 2023 Sep 26;13(1):16073. doi: 10.1038/s41598-023-43427-w. Sci Rep. 2023. PMID: 37752191 Free PMC article.
-
Nomogram for Risk of Secondary Venous Thromboembolism in Stroke Patients: A Study Based on the MIMIC-IV Database.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241254104. doi: 10.1177/10760296241254104. Clin Appl Thromb Hemost. 2024. PMID: 38772566 Free PMC article.
-
Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?Biochem Med (Zagreb). 2021 Jun 15;31(2):020708. doi: 10.11613/BM.2021.020708. Biochem Med (Zagreb). 2021. PMID: 34140831 Free PMC article.
-
Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients.Am J Transl Res. 2024 Oct 15;16(10):5797-5812. doi: 10.62347/EDAR9565. eCollection 2024. Am J Transl Res. 2024. PMID: 39544782 Free PMC article. Review.
References
-
- Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb). 2010;20:184–99.
-
- Harris NS, Bazydlo LAL, Winter WE. A Primer on Haemostasis for Clinical Chemists.Clinical Laboratory News 2012. Available at: https://www.aacc.org/publications/cln/articles2012/January/coagulation-t.... Accessed March 17th 2016.
-
- Chandler WL, editor. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 63-71. https://doi.org/10.1002/9781444303575.ch7 - DOI
-
- Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in haemostasis. Lab Med. 2012;43:1–10. 10.1309/LM749BQETKYPYPVM - DOI